|
1
|
Vescia S, Baumgärtner AK, Jacobs VR,
Kiechle-Bahat M, Rody A, Loibl S and Harbeck N: Management of
venous port systems in oncology: A review of current evidence. Ann
Oncol. 19:9–15. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Biffi R, Pozzi S, Agazzi A, Pace U,
Floridi A, Cenciarelli S, Peveri V, Cocquio A, Andreoni B and
Martinelli G: Use of totally implantable central venous access
ports for high-dose chemotherapy and peripheral blood stem cell
transplantation: Results of a monocentre series of 376 patients.
Ann Oncol. 15:296–300. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chang YF, Lo AC, Tsai CH, Lee PY, Sun S,
Chang TH, Chen CC, Chang YS and Chen JR: Higher complication risk
of totally implantable venous access port systems in patients with
advanced cancer - a single institution retrospective analysis.
Palliat Med. 27:185–191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yildizeli B, Laçin T, Batirel HF and
Yüksel M: Complications and management of long-term central venous
access catheters and ports. J Vasc Access. 5:174–178.
2004.PubMed/NCBI
|
|
5
|
Biffi R, Orsi F, Pozzi S, Pace U, Bonomo
G, Monfardini L, Della Vigna P, Rotmensz N, Radice D, Zampino MG,
et al: Best choice of central venous insertion site for the
prevention of catheter-related complications in adult patients who
need cancer therapy: A randomized trial. Ann Oncol. 20:935–940.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hartkamp A, van Boxtel AJ, Zonnenberg BA
and Witteveen PO: Totally implantable venous access devices:
Evaluation of complications and a prospective comparative study of
two different port systems. Neth J Med. 57:215–223. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Paleczny J, Banyś-Jafernik B, Gazurek K,
Kierpieć K, Szczerba H and Zipser P: Long-term totally implantable
venous access port systems - one center experience. Anaesthesiol
Intensive Ther. 45:215–222. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hung M-C, Chen C-J, Wu K-G, Hung GY, Lin
YJ and Tang RB: Subcutaneously implanted central venous access
device infection in pediatric patients with cancer. J Microbiol
Immunol Infect. 42:166–171. 2009.PubMed/NCBI
|
|
9
|
Narducci F, Jean-Laurent M, Boulanger L,
El Bédoui S, Mallet Y, Houpeau JL, Hamdani A, Penel N and Fournier
C: Totally implantable venous access port systems and risk factors
for complications: A one-year prospective study in a cancer centre.
Eur J Surg Oncol. 37:913–918. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hsieh C-C, Weng H-H, Huang W-S, Wang WK,
Kao C-L, Lu MS and Wang CS: Analysis of risk factors for central
venous port failure in cancer patients. World J Gastroenterol.
15:4709–4714. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li J, Fan YY, Xin MZ, Yan J, Hu W, Huang
WH, Lin XL and Qin HY: A randomised, controlled trial comparing the
long-term effects of peripherally inserted central catheter
placement in chemotherapy patients using B-mode ultrasound with
modified Seldinger technique versus blind puncture. Eur J Oncol
Nurs. 18:94–103. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lipitz-Snyderman A, Sepkowitz KA, Elkin
EB, Pinheiro LC, Sima CS, Son CH, Atoria CL and Bach PB: Long-term
central venous catheter use and risk of infection in older adults
with cancer. J Clin Oncol. 32:2351–2356. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Linnemann B: Management of complications
related to central venous catheters in cancer patients: An update.
Semin Thromb Hemost. 40:382–394. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Minassian VA, Sood AK, Lowe P, Sorosky JI,
Al-Jurf AS and Buller RE: Longterm central venous access in
gynecologic cancer patients. J Am Coll Surg. 191:403–409. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gallieni M, Pittiruti M and Biffi R:
Vascular access in oncology patients. CA Cancer J Clin. 58:323–346.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Del Molin A, Rasero L, Guerretta L,
Perfetti E and Clerico M: The late complications of totally
implantable central venous access ports: The results from an
Italian multicenter prospective observation study. Eur J Oncol
Nurs. 15:377–381. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Biffi R, de Braud F, Orsi F, Pozzi S,
Mauri S, Goldhirsch A, Nolè F and Andreoni B: Totally implantable
central venous access ports for long-term chemotherapy. A
prospective study analyzing complications and costs of 333 devices
with a minimum follow-up of 180 days. Ann Oncol. 9:767–773. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pittiruti M, Hamilton H, Biffi R, MacFie J
and Pertkiewicz M: ESPEN ESPEN Guidelines on Parenteral Nutrition:
Central venous catheters (access, care, diagnosis and therapy of
complications). Clin Nutr. 28:365–377. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Beckers MM, Ruven HJ, Seldenrijk CA, Prins
MH and Biesma DH: Risk of thrombosis and infections of central
venous catheters and totally implanted access ports in patients
treated for cancer. Thromb Res. 125:318–321. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mermel LA: Prevention of intravascular
catheter-related infections. Ann Intern Med. 132:391–402. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Groeger JS, Lucas AB, Thaler HT,
Friedlander-Klar H, Brown AE, Kiehn TE and Armstrong D: Infectious
morbidity associated with long-term use of venous access devices in
patients with cancer. Ann Intern Med. 119:1168–1174. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Villain-Guillot P, Gualtieri M, Bastide L
and Leonetti JP: In vitro activities of different inhibitors of
bacterial transcription against Staphylococcus epidermidis
biofilm. Antimicrob Agents Chemother. 51:3117–3121. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cooper GL, Schiller AL and Hopkins CC:
Possible role of capillary action in pathogenesis of experimental
catheter-associated dermal tunnel infections. J Clin Microbiol.
26:8–12. 1988.PubMed/NCBI
|
|
24
|
Raad I, Hachem R, Hanna H, Bahna P,
Chatzinikolaou I, Fang X, Jiang Y, Chemaly RF and Rolston K:
Sources and outcome of bloodstream infections in cancer patients:
The role of central venous catheters. Eur J Clin Microbiol Infect
Dis. 26:549–556. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Veenstra DL, Saint S and Sullivan SD:
Cost-effectiveness of antiseptic-impregnated central venous
catheters for the prevention of catheter-related bloodstream
infection. JAMA. 282:554–560. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee AY, Levine MN, Butler G, Webb C,
Costantini L, Gu C and Julian JA: Incidence, risk factors, and
outcomes of catheter-related thrombosis in adult patients with
cancer. J Clin Oncol. 24:1404–1408. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tesselaar ME, Ouwerkerk J, Nooy MA,
Rosendaal FR and Osanto S: Risk factors for catheter-related
thrombosis in cancer patients. Eur J Cancer. 40:2253–2259. 2004.
View Article : Google Scholar : PubMed/NCBI
|
